321,182
Participants
Start Date
December 31, 2014
Primary Completion Date
December 26, 2018
Study Completion Date
Warfarin
Apixaban
Dabigatran
Rivaroxaban
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY